Levroksin Injection (Levofloxacin Hemihydrate)
Levofloxacin Hydrate 5.1246mg
Prescription medication
Korea Pharma Co., Ltd.
MFDS item code 200501546 · Notified 2005.02.03 · Insurance code 653000431,653000441
Treatment of community-acquired pneumonia and complicated urinary tract infections
This drug is effective against a variety of bacteria, particularly targeting strains such as Enterococcus, Staphylococcus aureus, Streptococcus pneumoniae, and Escherichia coli. The main indications include community-acquired pneumonia, complicated urinary tract infections including acute pyelonephritis, complicated skin and soft tissue infections, acute sinusitis, and acute bacterial exacerbation of chronic bronchitis. However, due to the characteristics of fluoroquinolones, there is a risk of serious adverse reactions; therefore, this medication is used only when there are no alternative treatments for acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, and complicated skin and soft tissue infections. This medication is effectively used for the treatment of these infections.
Administered as a slow intravenous infusion 1 to 2 times a day. After the first few days of intravenous administration, it can be switched to oral administration based on the patient's condition, with the oral dose being the same as the intravenous dose. The method of administration must be solely through slow intravenous infusion, and it can be administered once or twice a day for a maximum of 14 days. The infusion time must take at least 60 minutes or more. For patients with normal kidney function (creatinine clearance > 50mL/min)
This medication is a fluoroquinolone antibiotic used for the treatment of bacterial infections. When using this drug, caution is advised as tendon-related issues such as tendinitis or tendon rupture may occur, especially with a risk of Achilles tendon rupture; if symptoms appear, the medication should be stopped immediately. Peripheral neuropathy or central nervous system adverse symptoms may also occur; if sensory disturbances or neurological symptoms arise, consult a physician immediately. Patients with myasthenia gravis may experience worsened symptoms when using this medication, thus it is advisable not to use it. This drug is primarily excreted through the kidneys, so patients with impaired kidney function require dosage adjustments and careful administration. When administered, intravenous injection of 250mg should be given slowly over at least 30 minutes, and 500mg over at least 60 minutes; if sudden drops in blood pressure or tachycardia occur, administration should be stopped immediately. This medication is not recommended for children or adolescents under 18 years of age, or for women who are pregnant or breastfeeding. Hypersensitivity reactions such as skin rash, urticaria, breathing difficulties, and anaphylaxis may occur; if any unusual symptoms appear, use should be stopped immediately and medical attention sought. Gastrointestinal symptoms such as nausea, diarrhea, and abdominal pain may occur; if severe diarrhea occurs, the possibility of pseudomembranous colitis must be considered. Neuropsychiatric symptoms may include headaches, dizziness, insomnia, anxiety, confusion, and in severe cases, hallucinations or suicidal thoughts, necessitating close monitoring of changes in mental state. This medication may interact with other drugs, so it is essential to consult with a doctor or pharmacist before use if taking anticoagulants, hypoglycemic agents, non-steroidal anti-inflammatory drugs, theophylline, etc. Excessive sunlight exposure may lead to photosensitivity reactions; hence, avoiding strong sunlight or artificial UV exposure is recommended, and if any unusual symptoms arise, discontinue use. Caution is advised as dizziness or drowsiness may occur when driving or operating machinery. In cases of overdose, central nervous system symptoms and cardiac rhythm abnormalities may arise, necessitating immediate emergency treatment, as it is not removed by hemodialysis. This medication should be stored in a sealed container away from air and light. It is essential to avoid direct sunlight and store at room temperature between 1 and 30 degrees Celsius.
Urticaria, severe swelling (angioedema, facial swelling), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rashes, blisters, skin peeling, pain in oral/ocular mucosa, severe dermatological reactions, asthma attacks, respiratory abnormalities accompanied by coughing and fever, respiratory problems, yellowing of the skin or eyes (jaundice), extreme lethargy, liver dysfunction (jaundice), sudden and severe headache, lightning-like pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to prevent exposure to air or light. It is essential to avoid direct sunlight and store in a cool room temperature, ideally between 1 and 30 degrees Celsius.
A clear yellowish liquid with a green tint in a glass vial for injection
50mL/bottle, 100mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Levofloxacin Hydrate 5.1246mg
Prescription medication
Korea Pharma Co., Ltd.

Levofloxacin Hydrate 100mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Levofloxacin 100mg
Tablet · Prescription medication
Jeil Pharmaceutical Co., Ltd.

Levofloxacin Hydrate 100mg
Tablet · Prescription medication
International Pharmaceuticals Co., Ltd.
Levofloxacin 5.1246mg
Prescription medication
Jeil Pharmaceutical Co., Ltd.

Levofloxacin Hydrate 100mg
Tablet · Prescription medication
SS Pharm Co., Ltd.

Levofloxacin Hydrate 102.49mg
Tablet · Prescription medication
Samchundang Pharmaceutical Co., Ltd.

Levofloxacin Hydrate 100mg
Tablet · Prescription medication
Medica Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.